- Home
- TPST vs ZCMD Comparison
TPST vs ZCMD Comparison
Compare TPST & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- ZCMD
- Stock Information
- Founded
- TPST 2011
- ZCMD 2012
- Country
- TPST United States
- ZCMD China
- Employees
- TPST N/A
- ZCMD N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- TPST Health Care
- ZCMD Real Estate
- Exchange
- TPST Nasdaq
- ZCMD Nasdaq
- Market Cap
- TPST 33.0M
- ZCMD 29.0M
- IPO Year
- TPST N/A
- ZCMD 2020
- Fundamental
- Price
- TPST $6.86
- ZCMD $1.24
- Analyst Decision
- TPST Hold
- ZCMD
- Analyst Count
- TPST 3
- ZCMD 0
- Target Price
- TPST $30.00
- ZCMD N/A
- AVG Volume (30 Days)
- TPST 247.2K
- ZCMD 634.8K
- Earning Date
- TPST 08-07-2025
- ZCMD 01-01-0001
- Dividend Yield
- TPST N/A
- ZCMD N/A
- EPS Growth
- TPST N/A
- ZCMD N/A
- EPS
- TPST N/A
- ZCMD N/A
- Revenue
- TPST N/A
- ZCMD $15,864,773.00
- Revenue This Year
- TPST N/A
- ZCMD N/A
- Revenue Next Year
- TPST N/A
- ZCMD N/A
- P/E Ratio
- TPST N/A
- ZCMD N/A
- Revenue Growth
- TPST N/A
- ZCMD N/A
- 52 Week Low
- TPST $5.35
- ZCMD $0.95
- 52 Week High
- TPST $30.03
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- TPST 49.91
- ZCMD 47.43
- Support Level
- TPST $6.87
- ZCMD $1.06
- Resistance Level
- TPST $7.25
- ZCMD $1.28
- Average True Range (ATR)
- TPST 0.67
- ZCMD 0.17
- MACD
- TPST -0.02
- ZCMD -0.01
- Stochastic Oscillator
- TPST 11.20
- ZCMD 20.70
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.